Table 6A - New
Diagnosis Codes
|
Diagnosis Code |
Description |
CC |
MDC |
MS-DRG |
|
040.41 |
Infant botulism |
Y CC |
15 18 |
7911
, 7931 867,
868, 869 |
|
040.42 |
Wound botulism |
Y CC |
18 |
867,
868, 869 |
|
058.10 |
Roseola infantum, unspecified |
N |
15 18 |
7911,
7931 865,
866 |
|
058.11 |
Roseola infantum due to human herpesvirus 6 |
N |
15 18 |
7911,
7931 865,
866 |
|
058.12 |
Roseola infantum due to human herpesvirus 7 |
N |
15 18 |
7911,
7931 865,
866 |
|
058.21 |
Human herpesvirus 6 encephalitis |
Y MCC |
1 15 25 |
23,24,97,
98, 99 7911, 7931 974,
975, 976 |
|
058.29 |
Other human herpesvirus encephalitis |
Y MCC |
1 15 25 |
23,
24,97, 98, 99 7911,
7931 974,
975, 976 |
|
058.81 |
Human herpesvirus 6 infection |
N |
9 |
606,
607 |
|
058.82 |
Human herpesvirus 7 infection |
N |
9 |
606,
607 |
|
058.89 |
Other human herpesvirus infection |
N |
9 |
606,
607 |
|
079.83 |
Parvovirus B19 |
Y CC |
18 |
865,
866 |
|
200.30 |
Marginal zone lymphoma, unspecified site, extranodal and solid organ sites |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.31 |
Marginal zone lymphoma, lymph nodes of head, face, and neck |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.32 |
Marginal zone lymphoma, intrathoracic lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825,840, 841, 842 974,
975, 976 |
|
200.33 |
Marginal zone lymphoma, intraabdominal lymph
nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.34 |
Marginal zone lymphoma, lymph nodes of axilla and upper limb |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.35 |
Marginal zone lymphoma, lymph nodes of inguinal region and lower limb |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.36 |
Marginal zone lymphoma, intrapelvic lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.37 |
Marginal zone lymphoma, spleen |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.38 |
Marginal zone lymphoma, lymph nodes of multiple sites |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.40 |
Mantle cell lymphoma, unspecified site, extranodal and solid organ sites |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.41 |
Mantle cell lymphoma, lymph nodes of head, face, and neck |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841,842 974,
975, 976 |
|
200.42 |
Mantle cell lymphoma, intrathoracic lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.43 |
Mantle cell lymphoma, intra-abdominal lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.44 |
Mantle cell lymphoma, lymph nodes of axilla and upper limb |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.45 |
Mantle cell lymphoma,lymph nodes of inguinal region and lower limb |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.46 |
Mantle cell lymphoma, intrapelvic lymph nodes |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841,842 974,
975, 976 |
|
200.47 |
Mantle cell lymphoma, spleen |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840, 841, 842 974,
975, 976 |
|
200.48 |
Mantle cell lymphoma, lymph nodes of multiple sites |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.50 |
Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.51 |
Primary central nervous system lymphoma, lymph nodes of head, face, and neck |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.52 |
Primary central nervous system lymphoma, intrathoracic lymph nodes |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.53 |
Primary central nervous system lymphoma, intra-abdominal lymph nodes |
Y CC |
17 25 |
820,821,
822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.54 |
Primary central nervous system lymphoma, lymph nodes of axilla and upper limb |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.55 |
Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.56 |
Primary central nervous system lymphoma, intrapelvic lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.57 |
Primary central nervous system lymphoma, spleen |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.58 |
Primary central nervous system lymphoma, lymph nodes of multiple sites |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.60 |
Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.61 |
Anaplastic large cell lymphoma, lymph nodes of head, face, and neck |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.62 |
Anaplastic large cell lymphoma, intrathoracic lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.63 |
Anaplastic large cell lymphoma, intra-abdominal lymph nodes |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 974,
975, 976 |
|
200.64 |
Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb |
Y CC |
17 25 |
820,
821, 822, 823, 824, 825, 840,
841, 842 |